de novo sequencing

본문 바로가기


Home > Product > de novo sequencing
Product
de novo sequencing
Posting date : Nov 04, 2018
Membership
Free Member Scince Nov 04, 2018
FOB Price
1
Min. Order Quantity
1
Supply Abillity
1
Port
1
Payment Terms
1
Package
1
Keyword :
Category
Contact
Alex
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
United States [US]
Brand Name
MtoZ Biolabs
HS-CODE
30-
Package & Delivery Lead Time
Package
1
Detailed Description
Accurate determination of protein sequences is fundamental in the development of commercial monoclonal antibodies, vaccines, and diagnostic kits. Traditional sequencing methods uses database searching for protein sequencing, and has limitations for sequencing the unknown proteins, which may not be included in the database. De novo sequencing is a novel sequencing methods, with no need for database searching, and therefore, is the optimal method for analyzing unknown proteins and antibodies. Based on the world's most advanced mass spectrometry instrument, Obitrap Fusion Lumos, and combined with rich experience in bioinformatics analysis, MtoZ Biolabs has established a whole new generation of de novo sequencing platform that can achieve accurate sequence analysis of monoclonal antibodies and proteins, independent of any database searching. The primary sequence of proteins and antibodies and any mutations on the sequence can be analyzed quickly and accurately, without any prior information of the protein.
Advantage of de novo sequencing:
• Advanced high-resolution mass spectrometry technology• 100% protein/antibody sequence coverage• 95% accuracy for sequencing the first amino acid• Minimum amount of sample required

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top